Literature DB >> 26047659

Efficient inhibition of infectious prions multiplication and release by targeting the exosomal pathway.

Didier Vilette1, Karine Laulagnier2,3, Alvina Huor4, Sandrine Alais5, Sabrina Simoes6, Romao Maryse6, Monique Provansal7, Sylvain Lehmann7, Olivier Andreoletti4, Laurent Schaeffer2, Graça Raposo6, Pascal Leblanc8.   

Abstract

Exosomes are secreted membrane vesicles of endosomal origin present in biological fluids. Exosomes may serve as shuttles for amyloidogenic proteins, notably infectious prions, and may participate in their spreading in vivo. To explore the significance of the exosome pathway on prion infectivity and release, we investigated the role of the endosomal sorting complex required for transport (ESCRT) machinery and the need for ceramide, both involved in exosome biogenesis. Silencing of HRS-ESCRT-0 subunit drastically impairs the formation of cellular infectious prion due to an altered trafficking of cholesterol. Depletion of Tsg101-ESCRT-I subunit or impairment of the production of ceramide significantly strongly decreases infectious prion release. Together, our data reveal that ESCRT-dependent and -independent pathways can concomitantly regulate the exosomal secretion of infectious prion, showing that both pathways operate for the exosomal trafficking of a particular cargo. These data open up a new avenue to regulate prion release and propagation.

Entities:  

Keywords:  Ceramide; Cholesterol; ESCRT; Exosomes; PrPSc; PrPres; Prions

Mesh:

Substances:

Year:  2015        PMID: 26047659     DOI: 10.1007/s00018-015-1945-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  79 in total

1.  Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein.

Authors:  N Nishida; D A Harris; D Vilette; H Laude; Y Frobert; J Grassi; D Casanova; O Milhavet; S Lehmann
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform.

Authors:  N Naslavsky; R Stein; A Yanai; G Friedlander; A Taraboulos
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

3.  4-hydroxytamoxifen leads to PrPSc clearance by conveying both PrPC and PrPSc to lysosomes independently of autophagy.

Authors:  Ludovica Marzo; Zrinka Marijanovic; Duncan Browman; Zeina Chamoun; Anna Caputo; Chiara Zurzolo
Journal:  J Cell Sci       Date:  2013-02-15       Impact factor: 5.285

4.  The seeds of neurodegeneration: prion-like spreading in ALS.

Authors:  Magdalini Polymenidou; Don W Cleveland
Journal:  Cell       Date:  2011-10-28       Impact factor: 41.582

5.  Prion-like properties of pathological TDP-43 aggregates from diseased brains.

Authors:  Takashi Nonaka; Masami Masuda-Suzukake; Tetsuaki Arai; Yoko Hasegawa; Hiroyasu Akatsu; Tomokazu Obi; Mari Yoshida; Shigeo Murayama; David M A Mann; Haruhiko Akiyama; Masato Hasegawa
Journal:  Cell Rep       Date:  2013-07-03       Impact factor: 9.423

6.  Cultured peripheral neuroglial cells are highly permissive to sheep prion infection.

Authors:  Fabienne Archer; Corinne Bachelin; Olivier Andreoletti; Nathalie Besnard; Gregory Perrot; Christelle Langevin; Annick Le Dur; Didier Vilette; Anne Baron-Van Evercooren; Jean-Luc Vilotte; Hubert Laude
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

7.  Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis.

Authors:  Catarina Gomes; Sascha Keller; Peter Altevogt; Júlia Costa
Journal:  Neurosci Lett       Date:  2007-09-20       Impact factor: 3.046

8.  Plasmacytoid dendritic cells sequester high prion titres at early stages of prion infection.

Authors:  Rocio Castro-Seoane; Holger Hummerich; Trevor Sweeting; M Howard Tattum; Jacqueline M Linehan; Mar Fernandez de Marco; Sebastian Brandner; John Collinge; Peter-Christian Klöhn
Journal:  PLoS Pathog       Date:  2012-02-16       Impact factor: 6.823

9.  The multivesicular body is the major internal site of prion conversion.

Authors:  Yang-In Yim; Bum-Chan Park; Rajgopal Yadavalli; Xiaohong Zhao; Evan Eisenberg; Lois E Greene
Journal:  J Cell Sci       Date:  2015-02-06       Impact factor: 5.285

10.  Paracrine diffusion of PrP(C) and propagation of prion infectivity by plasma membrane-derived microvesicles.

Authors:  Vincenzo Mattei; Maria Grazia Barenco; Vincenzo Tasciotti; Tina Garofalo; Agostina Longo; Klaus Boller; Johannes Löwer; Roberta Misasi; Fabio Montrasio; Maurizio Sorice
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

View more
  18 in total

1.  Extracellular vesicle-mediated communication in host-parasite interactions: insight from Fasciola hepatica.

Authors:  Eduardo de la Torre-Escudero; Mark W Robinson
Journal:  Ann Transl Med       Date:  2017-05

Review 2.  Lysosomal Quality Control in Prion Diseases.

Authors:  Priyanka Majumder; Oishee Chakrabarti
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

Review 3.  Cellular mechanisms responsible for cell-to-cell spreading of prions.

Authors:  Didier Vilette; Josquin Courte; Jean Michel Peyrin; Laurent Coudert; Laurent Schaeffer; Olivier Andréoletti; Pascal Leblanc
Journal:  Cell Mol Life Sci       Date:  2018-05-14       Impact factor: 9.261

Review 4.  Therapeutically harnessing extracellular vesicles.

Authors:  Lesley Cheng; Andrew F Hill
Journal:  Nat Rev Drug Discov       Date:  2022-03-02       Impact factor: 84.694

Review 5.  Extracellular vesicles with diagnostic and therapeutic potential for prion diseases.

Authors:  Arun Khadka; Jereme G Spiers; Lesley Cheng; Andrew F Hill
Journal:  Cell Tissue Res       Date:  2022-04-08       Impact factor: 5.249

6.  Stimulating the Release of Exosomes Increases the Intercellular Transfer of Prions.

Authors:  Belinda B Guo; Shayne A Bellingham; Andrew F Hill
Journal:  J Biol Chem       Date:  2016-01-14       Impact factor: 5.157

7.  Disruption of amyloid precursor protein ubiquitination selectively increases amyloid β (Aβ) 40 levels via presenilin 2-mediated cleavage.

Authors:  Rebecca L Williamson; Karine Laulagnier; André M Miranda; Marty A Fernandez; Michael S Wolfe; Rémy Sadoul; Gilbert Di Paolo
Journal:  J Biol Chem       Date:  2017-10-11       Impact factor: 5.157

Review 8.  Axonal maintenance, glia, exosomes, and heat shock proteins.

Authors:  Michael Tytell; Raymond J Lasek; Harold Gainer
Journal:  F1000Res       Date:  2016-02-22

Review 9.  Focus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic Systems.

Authors:  Shin-Ichiro Ohno; Gregor P C Drummen; Masahiko Kuroda
Journal:  Int J Mol Sci       Date:  2016-02-06       Impact factor: 5.923

Review 10.  Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseases.

Authors:  Carolyn Tallon; Kristen R Hollinger; Arindom Pal; Benjamin J Bell; Rana Rais; Takashi Tsukamoto; Kenneth W Witwer; Norman J Haughey; Barbara S Slusher
Journal:  Drug Discov Today       Date:  2021-03-31       Impact factor: 8.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.